BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference30 articles.
1. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013
2. Triple-negative breast cancer: therapeutic options;S Cleator;Lancet Oncol,2007
3. Uncovering a tumor suppressor for triple-negative breast cancers;JG Albeck;Cell,2011
4. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer;Y Eralp;Ann Oncol,2008
5. Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer;B Corkery;Ann Oncol,2009
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Utilization of Poly(2‐ethyl‐2‐oxazoline)‐ b ‐Poly(ε‐caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer;Macromolecular Bioscience;2020-11-16
2. Prostate cancer cell-specific BikDDA delivery by targeted polymersomes;Applied Nanoscience;2020-03-04
3. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer;Oncotarget;2016-04-22
4. Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma;Oncotarget;2015-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3